Active ingredientPentoxyverine CitrateCat. No. P-P055-001CAS 23142-01-0Family · Pharmaceutical analytical standards
Pentoxyverine
A centrally acting cough suppressant, also known as carbetapentane, patented in the mid-1950s by the chemist H. G. Morren; it is used for dry cough due to colds, bronchitis and sinusitis. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Besides calming cough it binds strongly to sigma-1 receptors in the nervous system and also has antispasmodic and local anaesthetic properties.
Go to the active ingredient →Active ingredientPentoxyverine CitrateCat. No. P-P055-001CAS 23142-01-0
Pharmacopoeial impurityPentoxyverine EP Impurity BCat. No. P-P055-002CAS 77-22-5
Pharmacopoeial impurityPentoxyverine EP Impurity ACat. No. P-P055-003CAS 77-55-4
Impurity1-PhenylcyclopentanecarbonitrileCat. No. P-P055-006CAS 77-57-6
Impurity1-PhenylcyclopentanecarboxamideCat. No. P-P055-007CAS 5296-89-9
Impurity6-Hydroxy-2-phenylhexanenitrileCat. No. P-P055-008CAS 105539-06-8
ImpurityPentoxyverine Impurity 1Cat. No. P-P055-010
ImpurityPentoxyverine Impurity 2Cat. No. P-P055-011
ImpurityPentoxyverine Impurity 3Cat. No. P-P055-012
ImpurityPentoxyverine Impurity 4Cat. No. P-P055-013
ImpurityPentoxyverine Impurity B CitrateCat. No. P-P055-014No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
ImpurityPentoxyverine impurity A CRSEDQM code Y0000098Family PentoxyverineImpurityPentoxyverine impurity B CRSEDQM code Y0000099Family PentoxyverineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.